3 Calc Sulph
HOMEOFORCE TISSUE SALTS 3 CALC SULPH is known to aid in the repair and regeneration of tissues. It is found in the blood, skin, connective tissues and glands.
It is indicated for Skin conditions, Wound healing & Abscesses
Available At:
Dosage:
- adults: 1 tablet
- children: Half a tablet
- infants: A quarter tablet, crushed and dissolved in water.
- general: Dissolve tablet(s) under the tongue 3 times daily.
- acute: Every half an hour (up to 12 times a day) or until improvement of symptoms, then resume general dosing.
Ingredients:
- Each tablet contains:
- Calcium sulphate (Calcarea sulphurica)
- Inactive ingredients:
- Lactose and magnesium stearate
- Contains sugar: Lactose 0,24 g/tablet
- Suitable for vegetarians.
Contraindications:
- Do not use HOMEOFORCE TISSUE SALTS 3 CALC SULPH if you are hypersensitive (allergic) to any of the ingredients.
Warnings & Special Precautions
If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.
Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner. Contains lactose. Patients with the rare hereditary conditions of galactose intolerance e.g. galactosaemia, Lapp lactase deficiency or glucose-galactose malabsorption should not take HOMEOFORCE TISSUE SALTS 3 CALC SULPH.
Contains lactose which may have an effect on the glycaemic control of patients with diabetes mellitus. This unregistered medicine has not been evaluated by SAHPRA for its quality, safety or intended use. Tissue Salts are safe in pregnancy and lactation; however, you should always consult with your healthcare provider.
ASCENDIS CONSUMER BRANDS (PTY) LTD. Reg-Nr. 2013/195936/07 | VAT 4460264361
1 Carey Street, Wynberg, Sandton, Gauteng, 2090, South Africa
healthinfo@ascendishealth.com
Helpline: +27 11 036 9420
© HOMEOFORCE 2026. All Rights Reserved
For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority.